Biobehavioral-Cytokine Interactions in Ovarian Cancer

Korábbi kezelés

• Patients with a diagnosis of borderline epithelial ovarian tumor (formerly: tumors of low malignant potential" or recurrent invasive epithelial ovarian, primary peritoneal, or fallopian tube cancer treated with chemotherapy or radiotherapy previously are excluded.
• Patients who received neoadjuvant chemotherapy for ovarian, primary peritoneal, or fallopian tube carcinoma are excluded.

Más betegség

• Non-epithelial ovarian cancers or metastases to the ovaries from organs are excluded.
• Previous cancer diagnosis except for basal cell carcinoma of the skin or history of lymphoma.
• Comorbid conditions: Addison's disease, autoimmune hepatitis, hepatitis B, hepatitis C, AIDS or HIV, lupus erythematosus, mixed connective tissue disease, rheumatoid arthritis.
• Inability to accurately answer questions (e.g. a condition such as dementia)

Életkor

• Pregnancy or age <18 years old

Egyéb

• Use of systemic glucocorticoids such as prednisone or decadron in the last 30 days

• Patients with a histologic diagnosis of epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer; FIGO stage I to IV defined surgically at the completion of the initial abdominal surgery and with appropriate tissue available for histologic evaluation.
• Patients with the following histologic epithelial cell types are eligible: serous adenocarcinoma, endometrioid adenocarcinoma, mucinous adenocarcinoma, undifferentiated carcinoma, clear cell carcinoma, mixed epithelial carcinoma, or adenocarcinoma not otherwise specified. However, the histologic features must be compatible with primary Mullerian epithelial adenocarcinoma.
• GOG performance status 0-3